Long-term immunological changes in azathioprine-treated MS patients

被引：5

作者：

Corsini, E ^{[1
]}

La Mantia, L ^{[1
]}

Gelati, M ^{[1
]}

Dufour, A ^{[1
]}

Milanese, C ^{[1
]}

Massa, G ^{[1
]}

Nespolo, A ^{[1
]}

Salmaggi, A ^{[1
]}

机构：

[1] Natl Neurol Inst C Besta, I-20133 Milan, Italy

来源：

NEUROLOGICAL SCIENCES | 2000年 / 21卷 / 02期

关键词：

multiple sclerosis; azathioprine; PBMNC subsets; sVCAM-1;

D O I：

10.1007/s100720070101

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The long-term immunological effects of azathioprine treatment have been investigated in 8 multiple sclerosis patients with different course of disease, chronic progressive (CP) or relapsing progressive (RP). We studied fluctuations in peripheral blood mononuclear cell subsets, IgG, IgM and soluble vascular cell adhesion molecule-1 (sVCAM-1), before and after 2 (T24) and 3 (T36) years of therapy. We observed a significant decrease in CD8(+) cells over time and a trend to lower percentage of CD3-CD56(+) cells at T24 and T36. CD4(+)CD45RA(+) cells in MS patients were lower than in healthy controls before therapy and reached values similar to those of healthy controls at T24 and T36. The remaining immunological parameters did not show any significant fluctuations.

引用

页码：87 / 91

页数：5

共 34 条

[1] SUPPRESSOR CELL-FUNCTION IN MULTIPLE-SCLEROSIS - CORRELATION WITH CLINICAL-DISEASE ACTIVITY [J].

ANTEL, JP ;

ARNASON, BGW ;

MEDOF, ME .

ANNALS OF NEUROLOGY, 1979, 5 (04) :338-342

[2] INTERFERONS AND MULTIPLE-SCLEROSIS [J].

ARNASON, BGW ;

REDER, AT .

CLINICAL NEUROPHARMACOLOGY, 1994, 17 (06) :495-547

[3] Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b [J].

Calabresi, PA ;

Tranquill, LR ;

Dambrosia, JM ;

Stone, LA ;

Maloni, H ;

Bash, CN ;

Frank, JA ;

McFarland, HF .

ANNALS OF NEUROLOGY, 1997, 41 (05) :669-674

[4]

CHATENOUD L, 1981, TRANSPLANT P, V13, P1651

[5]

Confavreux C, 1996, Mult Scler, V1, P379

[6]

CSEUZ R, 1990, BRIT J RHEUMATOL, V29, P358

[7] SERUM BIOCHEMISTRY IN RELATION TO THE ACTION OF AZATHIOPRINE IN RHEUMATOID-ARTHRITIS [J].

DIXON, JS ;

BIRD, HA ;

SITTON, NG ;

PICKUP, ME ;

LEATHAM, PA ;

WRIGHT, V .

AGENTS AND ACTIONS, 1983, 13 (04) :373-379

[8] CIRCULATING, SOLUBLE ADHESION PROTEINS IN CEREBROSPINAL-FLUID AND SERUM OF PATIENTS WITH MULTIPLE-SCLEROSIS - CORRELATION WITH CLINICAL ACTIVITY [J].

DOREDUFFY, P ;

NEWMAN, W ;

BALABANOV, R ;

LISAK, RP ;

MAINOLFI, E ;

ROTHLEIN, R ;

PETERSON, M .

ANNALS OF NEUROLOGY, 1995, 37 (01) :55-62

[9] Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: Predominant intrathecal release of vascular cell adhesion molecule-1 [J].

Droogan, AG ;

McMillan, SA ;

Douglas, JP ;

Hawkins, SA .

JOURNAL OF NEUROIMMUNOLOGY, 1996, 64 (02) :185-191

[10] INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

DUQUETTE, P ;

GIRARD, M ;

DESPAULT, L ;

DUBOIS, R ;

KNOBLER, RL ;

LUBLIN, FD ;

KELLEY, L ;

FRANCIS, GS ;

LAPIERRE, Y ;

ANTEL, J ;

FREEDMAN, M ;

HUM, S ;

GREENSTEIN, JI ;

MISHRA, B ;

MULDOON, J ;

WHITAKER, JN ;

EVANS, BK ;

LAYTON, B ;

SIBLEY, WA ;

LAGUNA, J ;

KRIKAWA, J ;

PATY, DW ;

OGER, JJ ;

KASTRUKOFF, LF ;

MOORE, GRW ;

HASHIMOTO, SA ;

MORRISON, W ;

NELSON, J ;

GOODIN, DS ;

MASSA, SM ;

GUTTERIDGE, E ;

ARNASON, BGW ;

NORONHA, A ;

REDER, AT ;

MARTIA, R ;

EBERS, GC ;

RICE, GPA ;

LESAUX, J ;

JOHNSON, KP ;

PANITCH, HS ;

BEVER, CT ;

CONWAY, K ;

WALLENBERG, JC ;

BEDELL, L ;

VANDENNOORT, S ;

WEINSHENKER, B ;

WEISS, W ;

REINGOLD, S ;

PACHNER, A ;

TAYLOR, W .

NEUROLOGY, 1993, 43 (04) :655-661

← 1 2 3 4 →